India's blood cancer treatment ecosystem spans government-funded tertiary centers, charitable institutions, and specialized hematology programs—each offering distinct cost structures and advanced therapy access. Patients navigating acute leukemia, lymphoma, or myeloma diagnoses can access chemotherapy, bone marrow transplantation, and emerging CAR-T therapy at costs 70-80% below international benchmarks[9]. Key Takeaways Government hospitals deliver thorough blood cancer trea